Cite

HARVARD Citation

    Tahir, H. et al. (n.d.). P250 Effect of secukinumab on radiographic progression through 2 years in patients with active PsA: end-of-study results from a Phase 3 study. Rheumatology. p. . [Online]. 
  
Back to record